Croda International (LON:CRDA) Price Target Cut to GBX 3,300 by Analysts at Citigroup

Croda International (LON:CRDA - Get Free Report) had its price objective reduced by equities researchers at Citigroup from GBX 3,550 ($47.11) to GBX 3,300 ($43.79) in a note issued to investors on Tuesday, MarketBeat reports. The firm presently has a "neutral" rating on the stock. Citigroup's price objective would indicate a potential upside of 9.00% from the company's current price.

Separately, Berenberg Bank reissued a "buy" rating and issued a GBX 3,800 ($50.42) target price on shares of Croda International in a research report on Thursday, April 24th.

Croda International Stock Up 0.9 %

Shares of LON CRDA traded up GBX 27.62 ($0.37) during trading on Tuesday, reaching GBX 3,027.62 ($40.18). 356,745 shares of the stock were exchanged, compared to its average volume of 1,567,817. The company has a market capitalization of £4.23 billion, a price-to-earnings ratio of 26.02, a price-to-earnings-growth ratio of 1.40 and a beta of 0.74. The business's 50-day moving average price is GBX 2,941.11 and its 200 day moving average price is GBX 3,254.09. The company has a quick ratio of 2.25, a current ratio of 2.72 and a debt-to-equity ratio of 30.90. Croda International has a twelve month low of GBX 2,551 ($33.85) and a twelve month high of GBX 4,932 ($65.45).

Croda International (LON:CRDA - Get Free Report) last released its quarterly earnings results on Tuesday, February 25th. The company reported GBX 142.60 ($1.89) EPS for the quarter. Croda International had a return on equity of 6.96% and a net margin of 9.98%. As a group, equities analysts forecast that Croda International will post 181.8307268 EPS for the current fiscal year.

Insider Buying and Selling at Croda International

In related news, insider Steve Foots sold 3,249 shares of the stock in a transaction dated Monday, March 24th. The shares were sold at an average price of GBX 2,909 ($38.60), for a total value of £94,513.41 ($125,415.88). Also, insider Tom Brophy sold 380 shares of Croda International stock in a transaction dated Monday, April 7th. The shares were sold at an average price of GBX 2,643 ($35.07), for a total transaction of £10,043.40 ($13,327.23). Insiders acquired a total of 570 shares of company stock worth $1,787,575 over the last 90 days. Insiders own 0.93% of the company's stock.

Croda International Company Profile

Founded in 1925 with the aim of turning bio-based raw materials into innovative ingredients, Croda International is a speciality chemicals company focused on consumer care and life sciences markets. The company is focused on creating, making and selling innovative ingredients that deliver real benefits to a diverse range of customers and employs more than 6,000 people around the world.